Femtech Market is expected to reach US$ 3.8 Bn by 2031, growing at a CAGR of 15.0% from 2021- 2031

Femtech is a term used for female technology which involves the use of digital health tools including software, diagnostics, products, and services that are targeted at women’s health. According to a recent Future Market Insights (FMI) report, the global femtech market is estimated to hit a valuation of US$ 948.1 Mn in 2021, with a market CAGR of 15.0% during the forecast period (2021-2031).

Market demand is set to rise at a steady pace throughout the forecast period, majorly favoured by investments outside the boundaries of healthcare towards a branched approach involving domains such as workplace regulations, financial equity, and state legislation.

The primary factor supporting the femtech market to positive expansion in terms of growth and stability is the advent of digitalization and artificial intelligence. Technological advancements such as cloud-based informatics allow personalized solutions, driven by consumer input. This has given rise to affordable and accessible analysis in terms of personal health monitoring and diagnosis.

Key market players have pushed for innovation and accessibility into customized digital solutions. This also includes the introduction of hands-free wearables which are assistive with the regular, day-to-day life of women across the globe.

Additionally, leading product developers in the femtech market work through commercial partners such as department stores, big-box retailers, hospitals, clinics, insurance companies, pharmacies and drugstores, private medical practices and e-commerce platforms to expand product sales prospects.

Get a Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-11761

Key Takeaways from Femtech Market Study

  • Menstrual health applications will drive market growth holding around a third of the market, supported by growing purchases from the working women demographic.
  • Diagnostic services are projected to cover about 45% of the global market by 2031. This is aided by the growing accessibility of digital health services
  • The U.S. holds a dominant share, valuing at over US$ 357.1 Mn by the end of 2021, supported by the presence of leading players and higher consumer acceptance.
  • The U.K. and Germany dominate the Europe market, cumulatively accounting for more than 25% of the regional revenue.
  • China is a leading market in East Asia, and is forecast to account for more than 50% of the regional value share owing to a vast consumer base.

“The advent of technological improvements in healthcare in the form of devices, applications, services, and products has increased the rate of diagnosis of reproductive disorders in terms of time management and treatments for women. This will aid growth through the upcoming decade,” says the FMI Analyst

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-11761

Who is Winning?

Some of the leading companies operating in the femtech market are focusing on collaborations with leading institutions for increasing awareness among the population about the adoption of digital health services.

Collaborations with key pharmaceutical companies to launch customized products and services for the growing consumer base has led key players to retain their position in the market while expanding their product portfolio.

  • Research collaboration in monitoring fetal heart rates through wearable ECG chips by between Bloomlife and Imec in 2019 has expectantly given rise to superior monitoring capabilities in maternity care.
  • Femtech companies have integrated applications for tracking fertility and offer services such as in-vitro fertilization. Additionally, they also offer medical treatments and products such as wearables and hands-free devices.

Key market players covered by FMI include Clue, Aparito Limited, Bloomlife, Bonzun Health Information AB, Elvie, Ava Science Inc., Grace Health, iBreve, LactApp, Natural Cycles Nordic AB, Hera Med Ltd., Niramai Health, NURX Inc., SteadySense GmbH, Pregnolia AG, Willow, WOOM and B-wom.

Ask Us Your Questions About This Report: https://www.futuremarketinsights.com/ask-question/rep-gb-11761

Want More Insights?

Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The global femtech market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on the femtech market based on service (diagnostics, monitoring, therapeutic), application (general health and wellness, maternity care, menstrual health, pelvic and uterine healthcare, cancer and chronic disease), and end-user (direct-to-consumer, hospitals, surgical centres, fertility clinics, diagnostics centres) across seven major regions.

Global Pneumococcal Vaccines Market Is Expected To Surpass A Valuation Of US$ 10124.9 Million By 2021, Expanding At A Value-Based CAGR Of 7.37% During The Forecast Period 2021 To 2031

Increasing incidence of pneumococcal diseases such as pneumonia, meningitis, and bacteremia is driving the market growth. According to a report published by Centers of Disease Control and Prevention in 2018, over 150,000 people in the U.S. are required emergency medical assistance due to pneumonia and approximately 3,500 deaths are reported in the country because of bacteremia and meningitis.

Get | Download Sample Copy with Graphs & List of Figures:
https://www.futuremarketinsights.com/reports/sample/rep-gb-7078

Kids under the age of 5 years and adult over 65 years of age a more vulnerable to pneumococcal diseases. Pneumococcal vaccines plays a significant role in safeguarding people and also assist in the treatment of these diseases. Thus, the demand to curb the rising incidence of pneumonia is expected to create lucrative growth opportunities for the market.

Government and various organization such as UNICEF, the WHO, and others across the globe are taking initiatives to spread the awareness and reduce the burden of pneumococcal diseases. Attributed to this, the public health agencies is expected to remain the dominant the distribution channel segment over the next ten years.

For More Information or Query or Customization Before Buying, Visit:
https://www.futuremarketinsights.com/customization-available/rep-gb-7078

Key Takeaways from FMI’s Pneumococcal Vaccines Market Study

  • The U.S. is anticipated to dominate the North America market on the back of high prevalence of pneumococcal diseases
  • The market in the U.K. is likely to grow at a steady pace, owing to the presence of leading market player in the country.
  • India will emerge as a highly lucrative market favored by the increasing number of government initiatives to curb the prevalence of pneumococcal diseases
  • Due to large pool of coronavirus and number of medical institutes and hospitals in China, the market in the country is likely to project rapid growth.
  • Based on product type, pneumococcal conjugate vaccines is estimated to lead the segment, supported by the increasing number of children vaccination programs.

“Several healthcare institutes, research centers, and leading manufacturers are focusing on research and development (R&D) and clinical trials for developing novel pneumococcal drugs to address the demand for vaccines for multiple serotypes. Their efforts are estimated to bode well for the market, spurring the sales,” says the FMI analyst.

For any queries linked with the report, ask an analyst
https://www.futuremarketinsights.com/ask-question/rep-gb-7078

Competitive Landscape

Leading players operating in the pneumococcal vaccines landscape are increasingly investing in research and development and conducting clinical trial for developing novel pneumococcal drugs. Besides this, some of the market players are focusing on receiving approvals from regulatory bodies to launch the products. For instance,

In January 2021, Pfizer Inc,, one of the leading pharmaceutical company, announced receiving an approval from the U.S. Food and Drug Administration (FDA) for its new drug named, PREVNAR 20. It is a pneumococcal conjugate vaccines for prevention of invasive disease and pneumonia caused by 20 pnemococcus stereotypes in adults aged 18 years or older.

On-site Preventive Care Market to reach USD 33.8 billion by 2028

Future Market Insights has published a new report titled “On-site Preventive Care Market: Global Industry Analysis (2017-2021) and Opportunity Assessment (2022-2028).” The report states that the standards set in the workplace for the safety of workers and the need to adhere to workplace norms have triggered the demand for on-site preventive care. Moreover, the increasing incidences of workplace illness has also made it an obligation for employers to follow employee safety codes and adopt on-site preventive care. As a result, the global On-Site Preventive Care Market is expected to witness a CAGR of 7.1% from 2022 to 2028. The market was worth around US$ 16,135 Mn in 2022 and is likely to touch a valuation of US$ 32,063 Mn approximately by the end of 2028.

On-site clinics enable employees to receive the required essential care at the time of emergency without having to leave the workplace. The clinicians in these clinics also aid employees in searching for a primary care physician who they can consult with on a regular basis. As a Future Market Insights analyst quotes, “Changes in lifestyle among the working class have incessantly impelled employers to establish certain behavioural standards within the workplace. This is one of the core factors responsible for the growing adoption of on-site preventive care in several organisations across the globe.”

To remain ‘ahead’ of your competitors, request for a sample-  https://www.futuremarketinsights.com/reports/sample/rep-gb-5518

Burgeoning Penetration of Workplace Wellness Programmes to Bode Well for the Market

In the recent past, workplace wellness programmes have earned the merit of being one of the most adopted healthcare services in the world. It has been further expected that its adoption will increase in the coming years owing to the implementation of the Affordable Care Act. This act is expected to promote an increase in the employee-based coverage of workplace wellness and also promote these programmes through several provisions. Moreover, the growing incidences of chronic diseases among the working population have also become a matter of concern and this has compelled employers across the globe to adopt as well as promote workplace wellness programmes.

Furthermore, employers who have adopted on-site preventive care services have reported enhanced performance ranging from heightened morale and cost savings to productivity. The death of time, access, and cost along with misunderstanding of the benefits of prescribed wellness programmes result in the underutilisation of primary care services. As a result, employees flood emergency rooms, missing out on critical preventive care measures and also leave chronic conditions go unmanaged. In this regard, on-site clinics provide employees with the necessary support without having to leave their work and plus the clinicians also work together with the patients in a cohesive environment to address their various health related issues.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-5518

North America and Western Europe to Compete Neck and Neck

In 2017, North America held a share of 37.0% in the global on-site preventive care market closely trailed by Western Europe. The dominance of North America can be attributed to the several policies implemented by the U.S. government pertaining to employee safety and the adoption of certain employee codes of safety. The U.S. is also an extremely mature market owing to the high adoption of workplace wellness programmes.

Companies to Innovate Services in the Global Market

In order to stay ahead of the competition, several companies operating in the global market are focussing on innovating their existing services and integrating new services. Some of the leading companies in the market are Premise Health, OnSite Care, Inc., PrevMED, RepuCare, Healthcare Solutions Centers, LLC, McCormack & Kale Motiva Health & Chiropractic, Inc., Marino Wellness, Kinema Fitness, and TotalWellness.

Reasons to Buy the report

  • We provide authentic and detailed an analysis on various market trends to enable businesses to make informed and beneficial decisions to attain competitive edge over key players.
  • Our analysts provide detailed market segmentation along with meaningful insights and extensive reports that other companies fail to include.
  • The report includes accurate analysis of the market and the current developing trends affecting the growth. FMI speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, industry experts. This ensures that the data collected is from highly reliable sources.

For in-depth competitive analysis, Buy Now-  https://www.futuremarketinsights.com/checkout/5518

About FMI

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

3D Printed Medical Devices Market to experience a significant growth rate of 16.1% CAGR from 2022 to 2028

Until late 2016, the key focus of most leading players in the 3D printed medical devices market was geographic expansion through acquisition and merger. In May 2016, Johnson & Johnson announced collaboration with a subsidiary of HP Inc. for manufacturing personalized healthcare solutions at reduced costs through 3D printing techniques. J&J collaborated with Organovo to carry out feasibility study on bio printed human tissue for testing new medications to work with Carbon 3D, famous for ultra-fast Continuous Liquid Interface Production (CLIP) technology for production of custom surgical devices.
The focuse is now gradually shifting towards expansion through strategic partnerships to improve their distribution network. For instance, in 2017, Envision partnered with ScanSource, Inc. to deliver 3D printing solutions to resellers in the Americas. Similarly, in 2018, 3D Systems and Stryker announced distribution partnership for VSP (Virtual Surgical Planning) and anatomical models for carniomaxillofacial specialty.

Currently heading towards a market value of over US$ 440 Mn, the global market for 3D printed medical devices is projected for stupendous growth at 16% CAGR during 2019 – 2029. North America will remain the leading market for 3D printed medical device sales, whereas the market attractiveness of Asia Pacific has been rising notably.

To remain ‘ahead’ of your competitors, request for a sample
The market growth is primarily assisted by advancements in 3D printing technology, surging government spending in healthcare sector, increasing usage of 3D printed medical devices for medical procedures, and relative simplification of the manufacturing process of 3D printed medical devices. Introduction of Computer-aided Design (CAD) for 3D printing can create trail ready devices, thereby reducing manufacturing time, time to market as well as operational cost.

Key Takeaways – 3D Printed Medical Devices Market Study

• Although metals and alloys are most preferably used for 3D printed medical devices, biomaterial inks are expected to gain traction during the forecast period owing to their highly biocompatible and versatile physical properties.
• PolyJet – InkJet 3D printing technology currently holds maximum share of 3D printed medical devices market. However, consistent development and adoption of innovative technologies may reduce the 3D printed medical devices market share of this technology during the forecast period.
• Use of 3D printing technology in orthopedic implants is shaping the future of 3D printed medical devices market. It currently accounts for nearly half of the market value.
• The consistently expanding patient pool and growing preference for personalized implants in joint replacement surgeries will remain key boosters to growth of 3D printed medical devices demand in orthopedics.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-1501

3D PRINTED MEDICAL DEVICES MARKET STRUCTURE ANALYSIS

• Key players are focusing on strengthening their position by establishing new facilities in North America. In order to increase their revenue share, major players in North America are entering into agreements with hospitals and academic institutes.

• Various manufacturers are targeting Asia and Europe through distribution agreements with local players.

• Some of the key players in the 3D printed medical devices market include

1. 3D Systems, Inc.,
2. EnvisionTEC, and
3. EOS GmbH Electro Optical Systems among others.

• Large medical device manufacturers are increasingly gaining interest in 3D technology for manufacturing. These medical device companies are thus investing in 3D technology through acquisitions. For an instance, GE Healthcare acquired 95% of share of Arcam AB in December 2017.

Learn More About Report Inclusions
Future market insights offers a unique perspective and actionable insights on 3D printed medical devices market in its latest study, presenting historical demand assessment from 2014 – 2018 and projections from 2019 – 2029 based on application (orthopedic implants, dental implants, carnio-maxillofacial Implant), material type (metals and alloys, biomaterial inks and plastics) technology (stereolithography (SLA) – liquid-based 3D printing, selective layer sintering (SLS) – powder-based 3d printing, digital light processing(DLP), fused deposition modelling (FDM)-plastic filament extrusion-based, polyjet – inkjet 3D printing, electronic beam melting (EBM) ) end user (hospitals, ambulatory surgical centers, diagnostic centers) in seven key regions.

For in-depth insights, Download a PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-1501

3D PRINTED MEDICAL DEVICES MARKET TAXONOMY

FMI’s study on the 3D printed medical devices market offers information divided into five important segments – application, material type, technology, end user, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Application

  • Orthopedic Implants
  • Dental Implants
  • Carnio-Maxillofacial Implant

Material Type

  • Metals and Alloys
  • Biomaterial Inks
  • Plastics

Technology

  • Stereolithography (SLA) – Liquid-based 3D Printing
  • Selective Layer Sintering (SLS) – Powder-based 3D Printing
  • Digital Light Processing(DLP)
  • Fused Deposition Modelling (FDM)-Plastic Filament Extrusion-based
  • PolyJet – InkJet 3D Printing
  • Electronic Beam Melting (EBM)

End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic Centers

Region

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • APEJ
  • JAPAN
    • Middle East and Africa

 

Surface Plasmon Resonance Market 2022 by Global Key Players, Types, Applications, Countries, Industry Size and Forecast to 2029

Increasing adoption of label-free detection techniques over labelled detection techniques is due to their cost-effective nature. Additionally, the availability of versatile products coupled with surface plasmon resonance to enhance the specificity of tests is an important factor that will bolster the demand for surface plasmon resonance. Imaging systems help in increasing throughput at a remarkable speed and with precise motion and consistency in report generation. Furthermore, the introduction of multifunctional products for improved outcomes is also expected to drive the growth of the surface plasmon resonance market over the forecast period.

The global surface plasmon resonance market is projected to reach a market value of US$ 770 Mn in 2019, increasing at a decent CAGR of 6% over the forecast period of 2019 – 2029.

“Increasing application of surface plasmon resonance in the field of drug discovery and medical imaging is contributing to the growth of the surface plasmon resonance market. Development of new technologies coupled with surface plasmon resonance, such as nanoparticle surface plasmon resonance and microfluidics, is playing an important role in the overall growth of the global surface plasmon resonance market.”

Get Report Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-962

Key Takeaways of Surface Plasmon Resonance Market Study

  • The market share of imaging systems is evaluated to grow at a significant rate by the end of 2029, as these are the ideal solution for the analysis of label-free and multiplexed biomolecules.
  • Sales of surface plasmon resonance are envisaged to be higher in North America. Increasing adoption of imaging systems and biosensors in life science R&D is anticipated to boost the growth of the surface plasmon resonance market in the region.
  • Innovation while developing imaging software used in surface plasmon resonance for the analysis of kinetic parameters of biomolecular interactions is a key aspect for increasing the reproducibility of results. Companies are investing in R&D initiatives to introduce superior imaging devices with enhanced magnification, to observe the smallest deflection in the refractive index, thus aiding the growth of the surface plasmon resonance market.

Any Queries, ask an Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-962

Adoption of Label-free Detection Technique for Analysis of Biomolecules

Detection of biological analytes through their physical properties is difficult. As a result, researchers rely on the addition of some sort of label to one or more of the analytes that need to be studied. Inclusion of this label for increasing specificity and accuracy has increased the cost of reagents and assays. To reduce assay cost and complexity while providing more qualitative information through labelled detection, adoption of the label-free detection technique such as surface plasmon resonance has increased, and is expected to fuel the growth of the global surface plasmon resonance market during the forecast period. The label-free detection technique simplifies the procedure by reducing the time and effort required for the development of the assay. Thus, increasing adoption of label-free detection techniques over labelled detection is expected to boost the growth of the global surface plasmon resonance market.

Want more insights?

The surface plasmon resonance market report, a new study by Future Market Insights, opines on the evolution of the global surface plasmon resonance market from 2014–2018, and presents demand projections for 2019–2029, on the basis of product type (imaging systems, sensor systems, and reagents), application (drug delivery, material science, and biosensors), and end user (academic and research institutes, food and beverage industry, biopharmaceutical companies, CROs, and others), across seven prominent regions.

Buy Industry Research Report @ https://www.futuremarketinsights.com/checkout/962

Reasons to Buy the report

  • We provide authentic and detailed an analysis on various market trends to enable businesses to make informed and beneficial decisions to attain competitive edge over key players.
  • Our analysts provide detailed market segmentation along with meaningful insights and extensive reports that other companies fail to include.
  • The report includes accurate analysis of the market and the current developing trends affecting the growth. FMI speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, industry experts. This ensures that the data collected is from highly reliable sources.

About FMI

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Global Peripheral Vascular Stents Market Reached A Valuation Of Around US$ 3.5 Bn In 2021, And Is Expected To Attain A Net Worth Of US$ 5.3 Bn By 2028

According to the latest market report published by Future Market Insights, titled ‘Peripheral Vascular Stents Market: Global Industry Analysis 2013 – 2021 and Opportunity Assessment 2022 – 2028’, the global peripheral vascular stents market is expected to expand at a CAGR of 6.6% over the forecast period 2022–2028.

Get | Download Sample Copy with Graphs & List of Figures:
https://www.futuremarketinsights.com/reports/sample/rep-gb-2091

FMI estimates that the global market for peripheral vascular stents is to be valued at US$ 2,822.5 Mn in 2022 and is expected to expand at CAGR of 6.6% over 2022–2028, to reach US$ 5,324.1 Mn by 2028 end. Based on product type, the self-expanding stents segment dominated the global peripheral vascular stents market, with over 52.1% value share in 2021. The segment is expected to grow at above 6.6% CAGR over the forecast period.

North America is expected to maintain its dominance in the global market due to regulatory approval of several new products such as drug eluting stents in the U.S., Europe and Japan. Increasing awareness of peripheral surgeries and prevalence of peripheral artery disease in developing countries such as India and Brazil remains the major factor driving the demand for peripheral vascular stents. Increasing in number end users and growing number of ambulatory surgical centres are the other major factors expected to drive the growth of the global peripheral vascular stents market.

An intravascular stent is a synthetic tubular mesh structure used for permanent implant in graft or native vasculature. A stent is basically designed to provide mechanical radial support after assigning; the support is meant to improve vessel patency over the life of the device. After the stent is placed in the intended location, it is expanded by a balloon or self-expanding mechanism.

For More Information or Query or Customization Before Buying, Visit:
https://www.futuremarketinsights.com/customization-available/rep-gb-2091

Global Peripheral Vascular Stents Market: Segmental Forecast

The global peripheral vascular stents market has been segmented on the basis of product type, artery type, end user and regions. Globally, the self-expanding stents is expected to be the most attractive segment from the manufacturers’ point of view. Although there is a high demand for drug eluting stents and the segment leads in terms of market volume in the forecast period, high price of drug eluting stents would lead to low revenue contribution of the product type segment. Among all the artery types, high demand of peripheral stents is expected to come from iliac artery segment due to growing prevalence for peripheral artery disease in many countries across the globe.

Global Peripheral Vascular Stents Market: Regional Analysis

In terms of value, the global peripheral vascular stents market is expected to expand at 6.6% CAGR over the forecast period of 2022–2028. With nearly 48.5% market share, North America dominated in the global peripheral vascular stents market in 2021, partly due to penetration of newly approved drug eluting stents in the U.S. Western Europe is expected to be the second large market globally, with the U.K., Italy, France and Germany being countries with high growth rates. APEJ is expected to be the second large market for peripheral vascular stents, primarily due to improving immunization access and availability of cost-effective surgeries.

For any queries linked with the report, ask an analyst
https://www.futuremarketinsights.com/ask-question/rep-gb-2091

Global Peripheral Vascular Stents Market: Competition Tracking

The market for peripheral vascular stents is consolidated with few players contributing over 55% of revenue share. The key players identified in the global market include Medtronic Plc., Becton, Dickinson and Company, Cardinal Health, Inc., B. Braun Melsungen AG, MicroPort Scientific Corporation, Boston Scientific Corporation, BIOTRONIK SE & Co. KG, Abbott Laboratories, W.L. Gore & Associates Inc., and Cook Medical Inc., among others. Acquisition of established products to gain immediate growth is the key strategy adopted by key players in the market.

Mobile Gamma Cameras Market Will Account for Revenues Worth US$ 75.2 Million By 2028

Advancements in healthcare technology – particularly in the surgery category – have led to an increasing adoption of gamma cameras.

Further, the numerous developments in radio nucleotides are anticipated to favour the adoption of solid state cameras and mobile gamma cameras.

SPECT is currently the biggest application of gamma cameras given the low cost, large suite of radioisotopes, and expanded use cases.

Request a Sample Report with Table of Contents and Figures: https://www.futuremarketinsights.com/reports/sample/rep-gb-7368

Having said this, PET is anticipated to witness fastest growth in terms of adoption, owing to the greater special resolution and sensitivity, brought about by the use of positron emitting radioisotope that provides more energy, contrast, and special resolution. These findings are presented in a new research study on the global mobile gamma cameras market by Future Market Insights (FMI).

According to FMI analysis, the high costs of PET as compared to SPECT are expected to be negated in the wake of development of high sensitivity and selective tracers. FMI predicts a growth rate of 4.8% for the mobile gamma cameras market during the 10 year period from 2018 to 2028. Revenue from the sales of mobile gamma cameras is estimated to reach US$ 75.2 Mn by 2028 end, up from US$ 47.2 Mn in 2018.

Shift Towards Dual Head Gamma Cameras and Premium Priced Hi-tech Products Trending the Mobile Gamma Cameras Market

Technology continues to remain a major enabler of revenue growth in the global mobile gamma cameras market. Being a high value-low volume market, technology plays a vital role in the mobile gamma cameras market, where the technologically advanced products are priced at a premium. The development of solid state sensors is slowly replacing the photomultiplier tube and this represents the biggest technological development in the mobile gamma cameras market followed by miniaturisation.

A notable trend being observed in the mobile gamma cameras market is the adoption shift towards dual head gamma cameras. Single head mobile gamma cameras have certain inherent disadvantages such as slow speed and lower density count leading to inability to perform different types of tests. This has resulted in an elevated demand for multiple head cameras. Dual head cameras increase total counts per stop, resulting in relatively lesser scan time and better image quality leading to enhanced accuracy in diagnosis.

Further, the latest mobile gamma cameras come with newer and better functionalities. Owing to advances in electronic components and software, modern mobile gamma cameras include advanced reconstruction algorithms and periodic updates that help boost scan speeds and image correction parameters. Advanced gamma camera software also facilitates more personalised patient scans by tracking patient activity and performing appropriate scans.

Our advisory services are aimed at helping you with specific, customised insights that are relevant to your specific challenges. Let us know about your challenges and our trusted advisors will connect with you: https://www.futuremarketinsights.com/askus/rep-gb-7368

Key Takeaways from the Research Study on Mobile Gamma Cameras

The report by Future Market Insights studies the growth trajectory of the global market for mobile gamma cameras and also presents detailed forecasts for the various segments of the market. Key insights from the report are highlighted below:

  • Ambulatory surgical centres will remain fastest growing end users of mobile gamma cameras, owing to a greater demand in point of care testing
  • North America represents the largest regional market for mobile gamma cameras while Asia Pacific is expected to be the fastest growing market
  • Single head mobile gamma cameras continue to remain dominant in terms of revenue owing to the small form factor and low cost; however, dual head mobile gamma cameras will witness rapid growth in demand on account of their high scanning speeds and better resolution
  • New product development and strong after sales service agreements with end users will remain key differentiating strategies of mobile gamma camera manufacturers

To know more about the various market push factors at play in the global mobile gamma cameras market, write in to Future Market Insights analysts at press@futuremarketinsights.com

About the Healthcare Division at Future Market Insights

Future Market Insights facilitates corporates, government, investors, and associated audiences in the healthcare sector to identify and accentuate vital aspects applicable to product strategy, regulatory landscape, technology evolution, and other crucial issues to achieve sustainable success. Our unique approach to gathering market intelligence equips you in devising innovation-driven trajectories for your business. Know more about our sector coverage here

Global Aortic Stents Grafts Market Is Forecast To Total US$ 2.15 Bn In 2022

The revision in the market size and volume forecasts has been carried out taking into account the impact of various macroeconomic indicators and other industry-based demand-driving factors, as well as the recent developments of the key market participants. In terms of revenue, the global aortic stent grafts market is projected to expand at a 7.6% CAGR over the forecast period of 2018–2028.

Get | Download Sample Copy with Graphs & List of Figures:
https://www.futuremarketinsights.com/reports/sample/rep-gb-865

North America is expected to contribute a high revenue share in the global aortic stent grafts market over the forecast period. North America is witnessing a large demand for aortic stent grafts due to high adoption of endovascular repair surgeries, which is expected to boost the growth of the aortic stent grafts market.

The global market is segmented based on product type, end users and region. Based on the product type the market is segmented into abdominal aortic stent graft and thoracic aortic stent grafts. Abdominal aortic stent graft product type segment is expected to represent high revenue share in the global aortic stent grafts market. The thoracic aortic stent graft segment is expected to gain significant share in the forecast period due to increasing focus of the manufacturers on product launch for TEVAR procedures. Based on end users, the market is segmented into the hospitals and ambulatory surgical centers/outpatient surgical centers. Among both the end users, the hospitals is expected to be the leading segment the market.

For More Information or Query or Customization Before Buying, Visit:
https://www.futuremarketinsights.com/customization-available/rep-gb-865

New product launches with improved stent graft designs are expected to provide enormous opportunities for the growth of the aortic stent grafts market and fulfil the demand from surgeons to overcome complications during surgeries. Increasing government initiatives to reduce the burden of abdominal aortic aneurysm, favourable recommendation and regulatory approvals, mergers, and acquisitions among manufacturers are the key market trends, which are expected to boost the growth of aortic stent grafts market.

Increasing prevalence of aortic aneurysm among the older population, favourable reimbursement policies, adoption of new minimally invasive technologies are the major factors expected to impel the growth of the aortic stents grafts market. Increasing number of government screening programs for people over 65 age has provided huge growth opportunities for the manufacturers operating in the aortic stent grafts market. However, product recalls and lack of skilled healthcare professionals are factors hindering the growth of the aortic stent grafts market.

For any queries linked with the report, ask an analyst
https://www.futuremarketinsights.com/ask-question/rep-gb-865

The market for aortic stent grafts market is consolidated with large number of major players operating in the global market. Examples of some of the key players identified in global aortic stent grafts market are Cook Medical, Inc., W.L. Gore & Associates, MicroPort Scientific Corporation Inc., Medtronic Plc., Lombard Medical, Inc., Endologix, INC., Terumo Corporation Inc., Cardinal Health Inc., Becton, Dickinson and Company, Cryolife Inc., and Lombard Medical Inc.

Western Blotting Processors Market is projected to reach a market value of just under US$ 329 Million towards the close of 2031

Automation is currently trending the western blotting processors market, as revealed in a comprehensive research study by Future Market Insights. From an estimated valuation of US$ 235.5 Mn in 2021, the western blotting processors market is projected to reach a market value of just under US$ 329 Mn towards the close of 2031, exhibiting a decadal CAGR of 11.5%, according to the research report by Future Market Insights. Conventional western blotting processors are relatively inconsistent in terms of the efficiency of detecting protein traces in samples.

While the technique of western blotting demands time and technical expertise, automation has magnified the process of throughput screening in western blotting, thereby facilitating increasing number of trials and accelerating the experimentation process.  Automated western blotting techniques enable the analysis of several samples at one go, with the only manual task being loading of the sample into the western blotting system.

Manufacturers are Accelerating Product Launches and Eyeing Offshoring as a Viable Growth Strategy

The market for western blotting processors is highly competitive with the top companies accounting for a larger part of global sales. Leading companies are acquiring smaller companies and expanding their production capacities to gain a larger share of the global market.

Companies in the western blotting processors market are leveraging the available market opportunities to launch their products in full gear in the global market. One of the market companies leveraged an unexploited demand for point-of-care HIV diagnostics as its key entry strategy in the western blotting processors market.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-7365

Product registration followed by commercialisation is accelerating the product launch process and creating healthy competition in the global market for western blotting processors.

Manufacturers of western blotting processors are setting up production facilities in other countries so as to benefit from access to cheap labour and resource expertise, and realign their distribution and customer oriented strategies.

Another key player in the western blotting processors market recently made a strategic investment in the offshore development of its life sciences facility with a mandate to engage in the manufacturing and distribution of molecular biology products to a global clientele.

Increasing Cases of HIV Enabling Western Blotting Processors Market Growth

The number of HIV cases across the world is increasing by the day, causing a burden on the global healthcare industry. Monitoring and controlling the HIV epidemic depends on early detection of anti-HIV antibodies in human blood.

Western blot is a confirmed test that can detect anti-HIV antibodies in blood serum samples. This is one of the factors leading to an increase in the adoption of western blotting processors.

Proteomics is extensively used in the pharmaceuticals industry to identify specific proteins associated with particular diseases, with western blotting finding application in new drug discovery. In the field of medical diagnostics, proteomics is used in the diagnosis of biomarkers that are essentially proteins present in body fluids.

Western blotting helps in quick diagnosis of diseases by identifying proteins that are produced when the human body contracts a disease. Besides the healthcare and pharmaceuticals industry, western blotting also finds application in the agriculture sector to establish protein characterisation in seed quality testing; and in the food and beverages industry to detect whey milk protein in commercial grade soy milk to check for possible adulteration.

Western Blotting Processors Market Growth Challenged by High Costs, Low Innovation, and Unreliability of Automated Devices

Advanced automated western blotting devices such as the high performance western blotting transfer system are highly priced than their traditional counterparts, thereby restricting adoption across several developing economies.

High cost of labour is another challenge in certain regions that continue to carry out protein tests using cheap traditional western blotting processors, thereby leading to time-consuming and high labour cost-inducing processes.

Then again, the global western blotting processors market has not witnessed notable innovation, with very few advanced products launched in recent years.

Further, results obtained from the western blotting process are not fully reliable or consistent and the devices need to be updated regularly to produce more efficient and reliable results. The aforementioned factors are challenging revenue growth of the global western blotting processors market.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-7365

Why Future Market Insights?

  •   Comprehensive analysis on evolving purchase pattern across different geographies
  •   Detailed insights of market segments and sub-segments for historical as well as forecast period
  •   A competitive analysis of prominent players and emerging players in the keyword market
  •   Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

 

Hearing Implants Demand will grow by 7.31% CAGR through 2031, Supplemented by Surging Sales of Cochlear Implants

Future Market Insights (FMI) has projected the hearing implants market to register impressive growth at 7.3% CAGR during the forecast period. Hearing implant market valuation will surpass US$ 1218 Mn by 2021-end.

Surge in cases of hearing disability among the children and elderly population across the globe is a major factor fuelling growth. As per report, the market grew at a steady rate, registering 5.1% CAGR from 2016 to 2020.

Rapid technological advancements and introduction of cochlear implants will boost the market growth. Healthcare professionals often recommend cochlear implants in place of hearing aids for cases with severe loss of hearing.

Moreover, favorable reimbursement policies, especially across India, will create attractive opportunities for hearing implant sales. Besides this, Japan and China will emerge as lucrative markets for sales in Asia.

FMI also projects the demand in the U.S. to rise at an impressive pace. Presence of a large pool of patients with hearing disabilities, especially among geriatric population will create conducive environment for market growth.

Adoption of advanced technologies such as speech recognition and launch of innovative gadgets attached with the hearing implants also will strengthen growth opportunities. Driven by these factors, the market will reach a valuation of 2.53 Bn by the end of 2031.

“Increasing cases of severe hearing loss among children and older people will boost the demand for hearing implants. Preference for cochlear hearing implant due to technological advancements and better hearing ability will create growth opportunities for market players,” says a Future Market Insights analyst.

Request a report sample to gain comprehensive insights at https://www.futuremarketinsights.com/reports/sample/rep-gb-492

Key Takeaways from Hearing Implant Market Survey

  • In terms of product type, cochlear implants will remain the most preferred type throughout the forecast period
  • Based on end-use, while hospitals are expected to witness high growth, presence of local ENT clinics will exhibit faster growth in the segment
  • The U.S. is projected to be dominant market for hearing implant throughout the forecast period
  • China and Japan are expected to witness significant growth backed by increased research and development activities carried out by manufacturers to develop advanced hearing implants
  • Rising prevalence of hearing loss across India will spur the demand for hearing implants in the country

Key Drivers

  • Growing prevalence of hearing loss across the globe will spur the market growth in the forthcoming years
  • Increasing adoption of smart hearing aids due to the growing incidence of noise-induced hearing loss will improve the demand for hearing implants
  • Technological advancements in the field of hearing implant and integration of artificial intelligence will propel the demand

Key Restraints

  • High cost of hearing implants, especially in emerging economies, is likely to restrict the market growth
  • Dearth of skilled professionals will create a challenge for the growth of hearing implant market
  • High cost factor and health risks arising from surgical procedures are restraining revenues in the global hearing implant market

Our advisory services are aimed at helping you with specific, customized insights that are relevant to your specific challenges. Let us know about your challenges and our trusted advisors will connect with you: https://www.futuremarketinsights.com/ask-question/rep-gb-492

Competitive Landscape

Key players are focusing on entering into collaborations and partnerships with other companies in order to gain competitive edge. Apart from this, they are introducing new products integrated with advanced technologies.

In June 2021, Oticon Medical announced that the U.S. Food and Drug Administration (FDA) has granted the premarket approval to the company’s Neuro System to treat individuals 18 years or older with bilateral severe-to-profound sensorineural hearing loss.

In February 2021, Cochlear Limited, the global leader in implantable hearing solutions, announced the partnership with leading hearing health experts to conduct the largest ever international clinical study of an investigational cochlear implant that releases a glucocorticoid (anti-inflammatory) drug therapy directly to the cochlea.

In December 2020, Sonova Holding AG, a leading provider of hearing solutions, announced that its U.S. subsidiary Advanced Bionics LLC has received FDA approval in the U.S. for its new Naída™ CI Marvel and Sky CI™ Marvel sound processors.

Prominent players operating in hearing implant market profiled by Future Market Insights include:

  • Cochlear Ltd.
  • MED-EL
  • William Demant Holding A/S
  • Advanced Bionics AG
  • Nurotron Biotechnology Co. Ltd.
  • Ototronix
  • Envoy Medical Corporation
  • Medtronic.
  • Others

More Valuable Insights on Market

In its latest report, Future Market Insights offers comprehensive insights on the global hearing implant market, presenting historical demand data (2016-2020) and forecast statistics for the period from 2021-2031. The study offers incisive coverage on the global hearing implant market with an unbiased analysis, segmented on the basis of:

By Product Type:

  • Cochlear Implants
  • Middle Ear Implants
  • Bone conduction Implants
  • Auditory brainstem implant

By End User:

  • Hospitals
  • ENT clinics
  • Ambulatory Surgical Centres

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific excluding China and Japan (APECJ)
  • Japan
  • China
  • Middle East & Africa (MEA)

Request Special Price for this Report to our Sales Executive@ https://www.futuremarketinsights.com/request-special-price/rep-gb-492